911142

Sciegen Pharmaceuticals Inc — FEI 3008298016

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 9, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Hauppauge, NY (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed